This is in line with a previous study that demonstrated a reduction in existing TTR deposits in a transgenic mouse model of TTR-mediated amyloidosis (ATTR amyloidosis) after siRNA-mediated knockdown of TTR [30]. The gene discussed is TTR; the disease is amyloidosis.